Access cutting-edge acute lymphoblastic leukemia treatment through this clinical trial at a research site in Memphis. Study-provided care at no cost to qualified participants.
Access acute lymphoblastic leukemia specialists in Memphis at no cost
This study follows strict safety protocols and ethical guidelines
All study-related acute lymphoblastic leukemia treatment provided free
This is a Phase II clinical trial testing the use of two antigen-directed therapies, inotuzumab and blinatumomab, as part of induction therapy for children and young adults with newly diagnosed B-cell precursor acute lymphoblastic leukemia and lymphoma. Primary Objective * To assess if the flow-cytometry assessed MRD-negative remission rate following an immunotherapy-based Induction in NCI-high risk patients without favorable genetic features is higher than the results of similar patients trea
Sponsor: St. Jude Children's Research Hospital
Check if you qualify for this acute lymphoblastic leukemia clinical trial in Memphis, TN
If you're searching for acute lymphoblastic leukemia treatment options in Memphis, TN, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Memphis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced acute lymphoblastic leukemia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.